biovision nec 1s

potent necroptosis inhibitor biovision nec 1s

Product Details:

Alternate Name 5-((7-Cl-1H-indol-3-yl)methyl)-3-methylimidazolidine-2,4-dione); 7-Cl-O-Nec-1
Peptide Sequence No
Appearance Yellow solid
CAS # 852391-15-2
Molecular Formula C₁₃H₁₂ClN₃O₂
Molecular Weight 277.71
Purity ≥96% by TLC and LC-MS
Solubility DMSO
SMILES CN1C(=O)C(NC1=O)CC2=CNC3=C2C=CC=C3Cl
InChi InChI=1S/C13H12ClN3O2/c1-17-12(18)10(16-13(17)19)5-7-6-15-11-8(7)3-2-4-9(11)14/h2-4,6,10,15H,5H2,1H3,(H,16,19)
InChi Key WIKGAEMMNQTUGL-UHFFFAOYSA-N
PubChem CID 643953
Handling Protect from light and moisture
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not For Use in Humans.
biovision nec 1s

biovision nec 1s

 

Descriptions:

A potent necroptosis inhibitor. Displays higher activity in inhibiting necroptosis in Jurkat cells than Nec-1 (Cat. No. 1864) (EC₅₀ = 210 nM versus EC₅₀ = 490 nM), as well as showing no nonspecific cytotoxicity at high concentrations (~100 mM). More useful for in-cell and in vivo experiments compared to Nec-1.

Abstract
Abdominal aortic aneurysm (AAA) is a common aortic disease with a progressive nature. There is no approved pharmacological treatment that would effectively slow the growth of the aneurysm or prevent rupture. Necrosis is a form of programmed necrosis that is regulated by receptor-interacting protein kinases (RIPs). We have recently shown that a lack of RIP3 in mice prevented aneurysm formation.

The aim of this study is to test whether disruptive necrosis affects the progression of existing aneurysms using RIP1 inhibitors Necrostatin-1 (Nec-1) and optimized forms of Nec-1, 7-Cl-O-Nec-1 (Nec-1 s). Seven days after induction of the aneurysm by elastase perfusion, mice were randomly administered DMSO, Nec-1 (3.2 mg / kg / day) and Nec-1s (1.6 mg / kg / day) by intraperitoneal injection. After sacrifice on day 14 of postaneurysm induction, the aortic expansion in the Nec-1s group (64.12 ± 4.80%) was significantly smaller than in the DMSO group (172.80 ± 13.68%) (P <0.05).

The mean aortic diameter of Nec-1-treated mice appeared to be smaller (121.60 ± 10.40%) than the DMSO group, although the difference was not statistically significant (P = 0.1). Histologically, the aortic structure of Nec-1s-treated mice appeared normal, with continuous and organized elastin layers and rich SMCs expressing αActin. In addition, Nect-1 treatment reduced macrophage infiltration and MMP9 accumulation and increased tropoelastin and lysyl oxidase aortic levels. Together, our data suggest that pharmacological inhibition of necrosis by Nec-1 stabilizes pre-existing aneurysms by reducing inflammation and promoting connective tissue repair.

 

EZSolution? Nec-1s
2535-1 each
EUR 151.2

IQ-1S
B1279-25 each
EUR 548.4

IQ-1S
B1279-5 each
EUR 183.6

Growth Medium 1S
78221 500 ml
EUR 650
Description: This liquid Growth Medium is a complete medium optimized to culture select BPS Bioscience cell lines.Optimized for Use With: CRISPRa (SAM) HeLa Cell Line (BPS Bioscience, #78193), CRISPRa (SAM) HepG2 Cell Line (BPS Bioscience, #78194)

(1S,3R)-ACPD
B6245-10 10 mg
EUR 564

(1S,3R)-ACPD
B6245-50 50 mg
EUR 2182.8

(1S,3R)-RSL3
HY-100218A 10mM/1mL
EUR 180

(1S)-(-)-α-Pinene
C7097-100 100mg
EUR 40

(1S)-(-)-α-Pinene
C7097-200 200mg
EUR 50

(1S)-(-)-alpha-Pinene
TBW01089 0.1mL Ask for price

(1S,3R)-3-aminocyclohexanol
20-abx184839
  • EUR 2097.60
  • EUR 961.20
  • 1 g
  • 250 mg

(1S,3S)-3-Aminocyclohexanol
20-abx184840
  • EUR 1646.40
  • EUR 777.60
  • 1 g
  • 250 mg

(1S)‐(+)‐10‐CAMPHORSULFONIC ACID
703001 each Ask for price

Milnacipran ((1S-cis) hydrochloride)
HY-B0168B 5mg
EUR 224.4

IQ-1S (free acid)
HY-100233 100mg
EUR 787.2

NPEC-caged-(1S,3R)-ACPD
B7369-10 10 mg
EUR 661.2

NPEC-caged-(1S,3R)-ACPD
B7369-50 50 mg
EUR 2590.8

(1S,2S,3R)-DT-061
HY-112929B 10mM/1mL
EUR 612

(1S,3R,5R)-PIM447 (dihydrochloride)
HY-19322C 50mg
EUR 2539.2

(1S)-(+)-Camphor-10-sulfonic acid
GK7715-25 25
EUR 31.7

(1S)-(+)-Camphor-10-sulfonic acid
GK7715-5 5
EUR 16.4

cis-(1S,2R)-2-Aminocyclopentanol hydrochloride
20-abx182399
  • EUR 594.00
  • EUR 3951.60
  • EUR 1395.60
  • 1 g
  • 25 g
  • 5 g

Microtubule Associated Protein 1S (MAP1S) Antibody
abx234975-100ug 100 ug
EUR 661.2

Tert-Butyl (1S,3R)-3-Hydroxycyclopentylcarbamate
20-abx185572
  • EUR 678.00
  • EUR 393.60
  • EUR 1612.80
  • 1 g
  • 250 mg
  • 5 g

(1S,3S)-Methyl 3-aminocyclopentanecarboxylate hydrochloride
abx186027-1g 1 g
EUR 3316.8

Microtubule Associated Protein 1S (MAP1S) Antibody
20-abx109998
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

(1S,2R)-2-(Boc-amino)cyclopentanecarboxylicacid
20-abx180085
  • EUR 427.20
  • EUR 2380.80
  • EUR 927.60
  • 1 g
  • 25 g
  • 5 g

Microtubule-associated protein 1S Polyclonal Antibody
42570-100ul 100ul
EUR 399.6

Microtubule Associated Protein 1S (MAP1S) Antibody
20-abx113745
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Microtubule Associated Protein 1S (MAP1S) Antibody
abx032611-400ul 400 ul
EUR 627.6

Microtubule Associated Protein 1S (MAP1S) Antibody
abx032611-80l 80 µl
EUR 343.2

Microtubule Associated Protein 1S (MAP1S) Antibody
20-abx002312
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

Human Microtubule-associated protein 1S (MAP1S)
1-CSB-RP135494h
  • EUR 456.00
  • EUR 256.80
  • EUR 1570.80
  • EUR 672.00
  • EUR 1047.60
  • EUR 314.40
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Microtubule-associated protein 1S(MAP1S),partial expressed in E.coli

Microtubule Associated Protein 1S (MAP1S) Antibody
abx145490-100ug 100 ug
EUR 469.2

Recombinant Microtubule Associated Protein 1S (MAP1S)
RPU58260-100ug 100ug
EUR 537.6

Recombinant Microtubule Associated Protein 1S (MAP1S)
RPU58260-1mg 1mg
EUR 2496

Recombinant Microtubule Associated Protein 1S (MAP1S)
RPU58260-50ug 50ug
EUR 418